Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David F Ackerley

Showing results (61-70 of 83) with videos related to

Pageof 9
Sort By:
International Journal of Molecular Sciences|June 27, 2024
Structural Evaluation of a Nitroreductase Engineered for Improved Activation of the 5-Nitroimidazole PET Probe SN33623Abigail V Sharrock, Jeff S Mumm, Elsie M Williams, et al.
Enzyme and Microbial Technology|November 20, 2022
Development of a compartmentalised self-replication protocol for selection of superior blunt-end DNA ligasesLuke J Stevenson, Katherine J Robins, Janine K Sharma, et al.
Disease Models & Mechanisms|July 4, 2023
An inducible model of chronic hyperglycemiaTori R Tucker, Courtney A Knitter, Deena M Khoury, et al.
Cell Chemical Biology|March 7, 2017
Engineering a Multifunctional Nitroreductase for Improved Activation of Prodrugs and PET Probes for Cancer Gene TherapyJanine N Copp, Alexandra M Mowday, Elsie M Williams, et al.
The Biochemical Journal|October 4, 2015
Nitroreductase gene-directed enzyme prodrug therapy: insights and advances toward clinical utilityElsie M Williams, Rory F Little, Alexandra M Mowday, et al.
Organic Letters|November 24, 2020
Total Synthesis and Bioactivity Studies of Fungal Metabolite (-)-TAN-2483BJordan A J McCone, Kalpani K Somarathne, Christopher L Orme, et al.
Molecular Cancer|June 14, 2013
Pseudomonas aeruginosa NfsB and nitro-CBI-DEI--a promising enzyme/prodrug combination for gene directed enzyme prodrug therapyLaura K Green, Sophie P Syddall, Kendall M Carlin, et al.
Pharmaceuticals (Basel, Switzerland)|February 26, 2022
Interrogation of the Structure-Activity Relationship of a Lipophilic Nitroaromatic Prodrug Series Designed for Cancer Gene Therapy ApplicationsAmir Ashoorzadeh, Alexandra M Mowday, Christopher P Guise, et al.
Elife|November 13, 2020
Intracellular complexities of acquiring a new enzymatic function revealed by mass-randomisation of active-site residuesKelsi R Hall, Katherine J Robins, Elsie M Williams, et al.
Biochemistry|August 13, 2019
Engineering <i>Escherichia coli</i> NfsB To Activate a Hypoxia-Resistant Analogue of the PET Probe EF5 To Enable Non-Invasive Imaging during Enzyme Prodrug TherapyElsie M Williams, Michelle H Rich, Alexandra M Mowday, et al.
Pageof 9

Showing results (61-70 of 83) with videos related to

Sort By:
Pageof 9
International Journal of Molecular Sciences|June 27, 2024
Structural Evaluation of a Nitroreductase Engineered for Improved Activation of the 5-Nitroimidazole PET Probe SN33623Abigail V Sharrock, Jeff S Mumm, Elsie M Williams, et al.
Enzyme and Microbial Technology|November 20, 2022
Development of a compartmentalised self-replication protocol for selection of superior blunt-end DNA ligasesLuke J Stevenson, Katherine J Robins, Janine K Sharma, et al.
Disease Models & Mechanisms|July 4, 2023
An inducible model of chronic hyperglycemiaTori R Tucker, Courtney A Knitter, Deena M Khoury, et al.
Cell Chemical Biology|March 7, 2017
Engineering a Multifunctional Nitroreductase for Improved Activation of Prodrugs and PET Probes for Cancer Gene TherapyJanine N Copp, Alexandra M Mowday, Elsie M Williams, et al.
The Biochemical Journal|October 4, 2015
Nitroreductase gene-directed enzyme prodrug therapy: insights and advances toward clinical utilityElsie M Williams, Rory F Little, Alexandra M Mowday, et al.
Organic Letters|November 24, 2020
Total Synthesis and Bioactivity Studies of Fungal Metabolite (-)-TAN-2483BJordan A J McCone, Kalpani K Somarathne, Christopher L Orme, et al.
Molecular Cancer|June 14, 2013
Pseudomonas aeruginosa NfsB and nitro-CBI-DEI--a promising enzyme/prodrug combination for gene directed enzyme prodrug therapyLaura K Green, Sophie P Syddall, Kendall M Carlin, et al.
Pharmaceuticals (Basel, Switzerland)|February 26, 2022
Interrogation of the Structure-Activity Relationship of a Lipophilic Nitroaromatic Prodrug Series Designed for Cancer Gene Therapy ApplicationsAmir Ashoorzadeh, Alexandra M Mowday, Christopher P Guise, et al.
Elife|November 13, 2020
Intracellular complexities of acquiring a new enzymatic function revealed by mass-randomisation of active-site residuesKelsi R Hall, Katherine J Robins, Elsie M Williams, et al.
Biochemistry|August 13, 2019
Engineering <i>Escherichia coli</i> NfsB To Activate a Hypoxia-Resistant Analogue of the PET Probe EF5 To Enable Non-Invasive Imaging during Enzyme Prodrug TherapyElsie M Williams, Michelle H Rich, Alexandra M Mowday, et al.
Pageof 9